Research Article
Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
Table 1
Patients clinical characteristic.
| | Variable | Median (range) or number (%) | value | | Stable | Exacerbation |
| | Number of subjects | 13 | 15 | — | | Female | 6 (46%) | 7 (46%) | 1.000 | | Age (mean) | 10.4 (7-15) | 13.1 (9-18) | 0.018 | | F508 del homozygous | 7 (54%) | 6 (40%) | 0.458 | | F508del heterozygous | 4 (30%) | 5 (33%) | 0.864 | | — | 3 (13%) | 0.177 | | BMI (median) | 16.6 (14.4-21.0) | 17.3 (14.03-19.5) | 0.890 | | Pancreatic insufficiency | 10 (77%) | 13 (87%) | 0.488 | | Diabetes | — | 3 (0.2%) | 0.087 | | Chronic P. aeruginosa infection | 4 (30%) | 8 (53%) | 0.219 | | Chronic S. aureus infection | 10 (76%) | 13 (87%) | 0.450 | | FEV1 at admission (% pred.) | 100.0 (92.0-126.0) | 69.5 (56.5-87.0) | <0.0001 | | FVC at admission (% pred.) | 98.0 (89.0-111.0) | 75.5 (69.5-88.0) | <0.0001 | | TLC (% pred.) | 118.5 (112.0-124.0) | 120.0 (108.5-128.5) | 0.278 | | RV (% pred.) | 187.5 (168.0-205.0) | 237.5 (201.0-296.0) | <0.0001 | | RV/TLC (% pred.) | 161.5 (136.0-176.0) | 194.5 (181.5-220.0) | <0.0001 | | Shwachman-Kulczycki scale | 85.0 (85.0-90.0) | 67.5 (60.0-77.5) | <0.0001 | | Brasfield score | 21.0 (18.0-23.0) | 15.0 (13.0-20.0) | <0.001 |
|
|
